Mitotic checkpoint kinase Mps1 (also known as TTK) activates the PKCα/ERK1/2 pathway but inhibits the PI3K/Akt pathway, resulting in the promotion of cell proliferation in colon cancer HT-29 and SW480 cells [137]. Here, PRKCA is linked to malignant colon neoplasm.